SINGAPORE (Oct 25): DBS Group Research is reinstating coverage on animal protein play Japfa with a “buy” on projections of an earnings turnaround in 1H18 which would stretch into 2H18 and FY19.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

Subscribe